Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | 231,70 € | 251,80 € | 8,68 % |
| Canopy Growth Corp | 9 | 0 | 5 | 0 | 0,47 € | 1,75 € | 273,13 % |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | 23,26 € | 54,94 € | 136,20 % |
| Xencor Inc. | 14 | 1 | 4 | 0 | 16,90 € | 31,70 € | 87,55 % |
| QIAGEN NV | 11 | 0 | 3 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Taro Pharmaceutical Industries Ltd | 10 | 0 | 3 | 0 | 40,00 € | - | - |
| Evotec SE | 6 | 2 | 3 | 1 | 9,81 € | 19,00 € | 93,68 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 2 | 0 | 47,55 € | 52,75 € | 10,93 % |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | 28,00 € | 41,81 € | 49,34 % |
| United Therapeutics | 21 | 0 | 2 | 0 | 287,90 € | 288,66 € | 0,26 % |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | 128,30 € | 140,87 € | 9,80 % |
| Emergent Biosolutions Inc. | 4 | 3 | 2 | 0 | 7,32 € | 7,45 € | 1,81 % |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | 14,93 € | 31,00 € | 107,66 % |
| Viatris Inc. | 3 | 0 | 2 | 0 | 9,54 € | 12,25 € | 28,35 % |
| Exelixis Inc. | 19 | 0 | 1 | 0 | 20,38 € | 26,01 € | 27,61 % |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | 39,00 € | 43,87 € | 12,48 % |
| Medpace Holdings Inc | 12 | 0 | 1 | 0 | 370,80 € | 419,82 € | 13,22 % |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | 6,70 € | 26,25 € | 291,62 % |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | 1,18 € | 2,40 € | 104,08 % |
| Alkermes plc | 14 | 2 | 1 | 0 | 22,40 € | 34,08 € | 52,15 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 1 | 0 | 37,40 € | 85,51 € | 128,64 % |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | 9,15 € | 17,64 € | 92,76 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 15,48 € | - | - |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 103,00 € | - | - |
| Icon plc | 21 | 0 | 0 | 0 | 295,90 € | 324,79 € | 9,76 % |